Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Cardiovascular Diseases

Will Wearable Devices be Streamlined in Healthc...

Wearable Devices, or "wearables", include a wide range of electronic devices or accessories, that are worn or embedded on the body. These microprocessors powered devices are capable of collecting a...

Dec 09, 2020

Creating Future of MedTech Industry with Artificial Intelligence
Creating Future of MedTech Industry with Artificial Intelligence

Artificial Intelligence is a breakthrough technology and has been used tremendously in this data-driven age, leading to a leap forward in the MedTech industry. Artificial Intelligence enrolls the use of advanced machine learning algorithms and fulfills the job, which has been tackled by humans for ages. It has flou...

Find More
Different-Types-of-Alternative-Medicine
The State of Alternative Medicine In The Healthcare

Alternative Medicine often referred to as “integrative,” or  “complementary” medicine,  including a wide range of medical treatments, products, practices, and health care systems that are not a part of standard/ conventional medical care. Alternative medicine is categorized together with complementary med...

Find More
Healthcare-Delivery-System
Healthcare Delivery System: What lies in the future?

The healthcare industry over the past decade has observed revolutionary changes. Technology along with human expertise has completely changed the process of prevention, diagnosis, and treatment of diseases at almost every level of the healthcare delivery system.  The health system or healthcare delivery sys...

Find More

More Views & Analysis

Delveinsight
Boehringer Ingelheim; Roche demonstrated new analyses of their drugs in patients with ILDs during the American Thoracic Society (ATS) Virtual conference

ATS 2020 Virtual is scheduled to be held from August 5 to August 10, and it is exciting to watch the key presentations by Pharmaceutical Companies specifically focused on pulmonary disease, critical illness, and sleep disorders. Boehringer Ingelheim presented new analyses of Ofev data in patients with chronic fi...

Find More

Familial Chylomicronemia Syndrome Market
Rejections and Withdrawals: Familial Chylomicronemia Syndrome Market Needs a Therapy sufficiently Effective, sufficiently Affordable

A rare autosomal recessive disorder, Familial chylomicronemia syndrome (FCS) affects 1 in 1 to 2 million people (Burnett and Hegele, 1999; Pouwels et al. 2008). As per DelveInsight, the total Familial chylomicronemia syndrome diagnosed prevalent population in the 7MM [the US, EU4 (Germany, Franc...

Find More

recent-pharma-news-and-update
Olema raises $54M; T3 Pharma bags $27M to advance bacterial cancer therapy program; Biofourmis and Chugai’s Collaboration; A new study on averting heart attack

Olema Oncology raises USD 54 Million for breast cancer program Olema Oncology has raised USD 54 million to push its lead program into the clinic and boost its R&D efforts in other areas.   The capital will bankroll a phase 1/2 study of the asset, OP-1250, as a single agent. Olema Oncology will a...

Find More

Leading-Causes-of-Death-Worldwide
What are the Top Five Leading Causes of Deaths in the World?

The global healthcare system over the past few decades has transformed exponentially. Today we are living twice as long as our ancestors have lived before. Infrastructure development, technological advancements (such as accurate diagnosis and lesser medical errors), public-private partnerships in healthcare, availa...

Find More

Dilated Cardiomyopathy Market
With the Advances in Regenerative Therapy to Offer Curated Treatment Options, Off-label Therapy Market is Set to Decline for Dilated Cardiomyopathy

The Dilated Cardiomyopathy Market Size in the 7MM is expected to increase at a CAGR of 13.1% for the study period 2017-30. Dilated Cardiomyopathy (DCM) is one of the most common types of cardiomyopathies, i.e., diseases of heart muscles. Dilated Cardiomyopathy is a disease that results from the stretching and e...

Find More

Precision-Medicine
Precision Medicine: An emerging approach to conventional treatment

As per WHO, “Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer”. The patients whose lives are afflicted with similar types of cancers have long been administered a similar type of treatment regimen b...

Find More

Anorexia is the loss of the desire to eat, whereas cachexia results from the skeletal muscle mass in.....

Find More

Retinitis pigmentosa is a gradual deterioration of the ability of eyes to see. The defect in the eye.....

Find More

Herpes zoster oticus (HZ oticus) is a viral infection of the inner, middle, and external ear. A resu.....

Find More

Systemic scleroderma (SSC or systemic sclerosis) is an autoimmune disorder that results into scar ti.....

Find More

Rheumatoid Arthritis (RA) is a chronic, inflammatory autoimmune disease that leads to progressive an.....

Find More

Cystic fibrosis (CF) is a hereditary condition leading to chronic lung infections and eventually dec.....

Find More